Skip to main content
Clinical Trials/NCT01221480
NCT01221480
Completed
Not Applicable

Beta-Blockers Reduce Mortality and Exacerbations When Added to Stepwise Inhaled Therapy for COPD Without Adverse Effects on Lung Function.

University of Dundee0 sites5,977 target enrollmentAugust 2010
ConditionsCOPD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
University of Dundee
Enrollment
5977
Primary Endpoint
All-cause Mortality
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The aim of this observational study is to utilise the established record linkage data available in Tayside to investigate hospital admissions, exacerbations and mortality in COPD.

Registry
clinicaltrials.gov
Start Date
August 2010
End Date
October 2010
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Data collected through TARDIS database

Exclusion Criteria

  • History of asthma or malignancy. Less than 50 years of age

Outcomes

Primary Outcomes

All-cause Mortality

Time Frame: 3000 days

All-cause Mortality

Secondary Outcomes

  • Hospital Admissions(3000 days)
  • COPD exacerbations(3000 days)

Similar Trials